(Q40086294)

17 September 2017

1 reference

title

The drug treatment of anxiety (English)

1 reference

17 September 2017

The Drug Treatment of Anxiety (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

9 August 2023

author name string

Rosenbaum JF

1

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 February 1982

1 reference

17 September 2017

18 February 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6120458

full work available at URL

9 August 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM198202183060705

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

The New England Journal of Medicine

9 August 2023

published in

1 reference

17 September 2017

306

1 reference

17 September 2017

7

1 reference

17 September 2017

401-404

1 reference

Psychic distress, life crisis, and use of psychotherapeutic medications: national household survey data

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Are benzodiazepines overused and abused?

9 August 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Anxiety states (anxiety neurosis): a review

9 August 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Physical Illness Presenting as Psychiatric Disease

9 August 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Morbidity and Rate of Undiagnosed Physical Illnesses in a Psychiatric Clinic Population

9 August 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

9 August 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

A family study of anxiety neurosis. Morbidity risk in families of patients with and without mitral valve prolapse.

9 August 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Drug therapy. Benzodiazepines (second of two parts).

9 August 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Benzodiazepines: a summary of pharmacokinetic properties

9 August 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Diazepam disposition determinants.

9 August 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

The effects of age and liver disease on the disposition and elimination of diazepam in adult man

9 August 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Length of treatment with anxiolytic sedatives and response to their sudden withdrawal

9 August 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Ethanol and oral diazepam absorption

9 August 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Diazepam and human memory: influence on acquisition, retrieval, and state-dependent learning.

9 August 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Effect of pregnenolone--16 alpha-carbonitrile (PCN) on bilirubin clearance in man.

9 August 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Low-Dose Neuroleptic Regimens in the Treatment of Borderline Patients

9 August 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

Benzodiazepines — Panacea or Poison?

9 August 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM198202183060705

9 August 2023

Identifiers

1 reference

17 September 2017

1 reference